Clicky

Friday, November 20, 2026
All public companies · Official EDGAR

ANNXAnnexon, Inc.

Nasdaq · CIK 0001528115
Filer categoryNon-accelerated filer<br>Smaller reporting company
Entity typeoperating
SIC2834 Pharmaceutical Preparations
FY end1231
XBRL facts258

Identity from submissions API

NameAnnexon, Inc.
CIK0001528115
TickersANNX
ExchangesNasdaq
Entity typeoperating
CategoryNon-accelerated filer<br>Smaller reporting company
SIC2834 Pharmaceutical Preparations
EIN275414423
LEI—
Fiscal year end1231
State of incorporationDE DE
Phone(650) 822-5500
Website—
Investor website—
Owner org03 Life Sciences
Flags—
Description—
Insider transactions (issuer)1
Insider transactions (owner)0

Former names

  • None listed.
Business address
1400 SIERRA POINT PARKWAY
BLDG C, SUITE 200
BRISBANE
CA
94005
CA
Mailing address
1400 SIERRA POINT PARKWAY
BLDG C, SUITE 200
BRISBANE
CA
94005
CA

EDGAR has no company-logo API. Website field is shown when the filer provided one.

Financialist coverage

SEC filings

526 filing rows loaded from submissions recent.

FiledFormDocumentItemsAccessionFile no.FilmActSizeXBRLiXBRL
2026-11-20 4 xslF345X06/form4-11202026_041102.xml 0001824280-26-000007 4955
2026-11-16 SCHEDULE 13G/A xslSCHEDULE_13G_X02/primary_doc.xml 0000921895-26-003167 005-91583 261560531 34 23427
2026-11-09 10-Q 10-Q 0001193125-26-453585 001-39402 261535980 34 10198090 1 1
2026-11-09 8-K 8-K 2.02,9.01 0001193125-26-453557 001-39402 261535867 34 471264 1 1
2026-11-05 SCHEDULE 13G/A xslSCHEDULE_13G_X02/primary_doc.xml 0000315066-26-002696 005-91583 261526094 34 11717
2026-09-25 4 xslF345X06/form4-09252026_040908.xml 0001818520-26-000003 5531
2026-08-13 144 xsl144X01/primary_doc.xml 0001959173-26-005993 001-39402 261272808 33 5645
2026-08-12 4 xslF345X06/form4-08122026_100821.xml 0001614869-26-000004 5836
2026-08-12 3 xslF345X06/form3-08122026_100845.xml 0001614869-26-000003 11368
2026-08-12 10-Q 10-Q 0001193125-26-346779 001-39402 261267301 34 9328547 1 1
2026-08-12 8-K 8-K 2.02,8.01,9.01 0001193125-26-345672 001-39402 261265221 34 260000 1 1
2026-08-10 8-K 8-K 5.02,7.01,9.01 0001193125-26-342524 001-39402 261259021 34 172132 1 1
2026-08-07 SCHEDULE 13G xslSCHEDULE_13G_X02/primary_doc.xml 0000093751-26-000411 005-91583 261251571 34 8152
2026-08-06 8-K 8-K 8.01,9.01 0001193125-26-336867 001-39402 261246204 34 176313 1 1
2026-07-30 8-K 8-K 1.01,2.03,8.01,9.01 0001193125-26-326199 001-39402 261223679 34 536658 1 1
2026-07-27 SCHEDULE 13G/A xslSCHEDULE_13G_X02/primary_doc.xml 0002012383-26-002180 005-91583 261206073 34 11002
2026-07-15 144 xsl144X01/primary_doc.xml 0001959173-26-005238 001-39402 261177590 33 5006
2026-07-14 144 xsl144X01/primary_doc.xml 0001959173-26-005219 001-39402 261173760 33 4357
2026-07-08 SCHEDULE 13G/A xslSCHEDULE_13G_X02/primary_doc.xml 0001104659-26-082022 005-91583 261163804 34 13562
2026-07-08 SCHEDULE 13G/A xslSCHEDULE_13G_X02/primary_doc.xml 0000315066-26-001457 005-91583 261161039 34 11296
2026-06-15 4 xslF345X06/form4-06152026_040615.xml 0001553338-26-000001 5785
2026-06-15 4 xslF345X06/form4-06152026_040611.xml 0001315797-26-000002 5786
2026-06-15 4 xslF345X06/form4-06152026_040609.xml 0001373097-26-000001 5751
2026-06-15 4 xslF345X06/form4-06152026_040607.xml 0001900452-26-000001 5775
2026-06-15 4 xslF345X06/form4-06152026_040605.xml 0001650126-26-000001 5756
2026-06-15 4 xslF345X06/form4-06152026_040603.xml 0001824280-26-000005 5772
2026-06-15 4 xslF345X06/form4-06152026_040601.xml 0001818525-26-000004 6996
2026-06-12 8-K 8-K 5.07 0001193125-26-269479 001-39402 261086903 34 153843 1 1
2026-05-29 4 xslF345X06/form4-05292026_090557.xml 0001315797-26-000001 6221
2026-05-15 SCHEDULE 13G/A xslSCHEDULE_13G_X02/primary_doc.xml 0000921895-26-001383 005-91583 26986832 34 23552
2026-05-13 4 xslF345X06/form4-05132026_040507.xml 0001824280-26-000004 4956
2026-05-07 10-Q 10-Q 0001193125-26-211931 001-39402 26953421 34 8089705 1 1
2026-05-07 8-K 8-K 2.02,9.01 0001193125-26-211863 001-39402 26953111 34 386274 1 1
2026-04-27 ARS ARS 0001140361-26-017091 001-39402 26900999 34 3249514
2026-04-27 DEFA14A DEFA14A 0001140361-26-017088 001-39402 26900934 34 421008
2026-04-27 DEF 14A DEF 14A 0001140361-26-017085 001-39402 26900905 34 5297328 1 1
2026-04-16 PRE 14A PRE 14A 0001140361-26-015123 001-39402 26867579 34 5314901 1 1
2026-04-14 4 xslF345X06/form4-04142026_080436.xml 0001824280-26-000003 4956
2026-03-31 S-3ASR S-3ASR 0001193125-26-132688 333-294758 26816089 33 2969935 1 1
2026-03-31 S-8 S-8 0001193125-26-132652 333-294754 26816023 33 188642 1 1
2026-03-30 10-K 10-K 0001193125-26-131782 001-39402 26813141 34 14494306 1 1
2026-03-30 8-K 8-K 2.02,9.01 0001193125-26-131746 001-39402 26813022 34 442706 1 1
2026-03-26 SCHEDULE 13G/A xslSCHEDULE_13G_X02/primary_doc.xml 0000102909-26-000619 005-91583 26797693 34 7183
2026-03-12 4 xslF345X05/form4-03122026_040329.xml 0001824280-26-000002 4819
2026-03-04 4 xslF345X05/form4-03042026_040342.xml 0001734424-26-000003 5379
2026-03-04 4 xslF345X05/form4-03042026_040340.xml 0001818522-26-000003 5390
2026-03-04 4 xslF345X05/form4-03042026_040338.xml 0001818525-26-000003 5382
2026-03-04 4 xslF345X05/form4-03042026_040336.xml 0001958523-26-000003 5398
2026-03-04 4 xslF345X05/form4-03042026_040334.xml 0001465994-26-000003 5366
2026-03-02 144 xsl144X01/primary_doc.xml 0001959173-26-001728 001-39402 26709085 33 5150
2026-03-02 144 xsl144X01/primary_doc.xml 0001959173-26-001717 001-39402 26708506 33 5172
2026-03-02 144 xsl144X01/primary_doc.xml 0001959173-26-001702 001-39402 26707862 33 5177
2026-03-02 144 xsl144X01/primary_doc.xml 0001959173-26-001700 001-39402 26707538 33 5169
2026-03-02 144 xsl144X01/primary_doc.xml 0001959173-26-001699 001-39402 26707440 33 5153
2026-02-23 4 xslF345X05/form4-02242026_120218.xml 0001818520-26-000001 5700
2026-02-23 4 xslF345X05/form4-02242026_120253.xml 0001734424-26-000002 7634
2026-02-23 4 xslF345X05/form4-02242026_120238.xml 0001818522-26-000002 7645
2026-02-23 4 xslF345X05/form4-02242026_120223.xml 0001958523-26-000002 7653
2026-02-23 4 xslF345X05/form4-02242026_120245.xml 0001818525-26-000002 7637
2026-02-23 4 xslF345X05/form4-02242026_120245.xml 0001465994-26-000002 7621
2026-02-20 4 xslF345X05/form4-02202026_040203.xml 0001734424-26-000001 5378
2026-02-20 4 xslF345X05/form4-02202026_040201.xml 0001465994-26-000001 5367
2026-02-20 4 xslF345X05/form4-02202026_040209.xml 0001958523-26-000001 5400
2026-02-20 4 xslF345X05/form4-02202026_040207.xml 0001818525-26-000001 5382
2026-02-20 4 xslF345X05/form4-02202026_040205.xml 0001818522-26-000001 5390
2026-02-18 144 xsl144X01/primary_doc.xml 0001959173-26-001147 001-39402 26647875 33 4508
2026-02-18 144 xsl144X01/primary_doc.xml 0001959173-26-001146 001-39402 26647867 33 4527
2026-02-18 144 xsl144X01/primary_doc.xml 0001959173-26-001142 001-39402 26647767 33 4507
2026-02-18 144 xsl144X01/primary_doc.xml 0001959173-26-001137 001-39402 26647693 33 4522
2026-02-18 144 xsl144X01/primary_doc.xml 0001959173-26-001133 001-39402 26647615 33 4520
2026-02-17 8-K 8-K 5.02 0001193125-26-054695 001-39402 26641566 34 140609 1 1
2026-02-17 SCHEDULE 13G/A xslSCHEDULE_13G_X01/primary_doc.xml 0001104659-26-016434 005-91583 26641517 34 19384
2026-02-05 SCHEDULE 13G/A xslSCHEDULE_13G_X01/primary_doc.xml 0000315066-26-000364 005-91583 26601831 34 11455
2026-01-21 SCHEDULE 13G/A xslSCHEDULE_13G_X01/primary_doc.xml 0002012383-26-000639 005-91583 26545844 34 10838
2026-01-14 8-K 8-K 7.01,9.01 0001193125-26-012918 001-39402 26533341 34 11968803 1 1
2026-01-12 8-K 8-K 8.01,9.01 0001193125-26-009740 001-39402 26524633 34 176728 1 1
2026-01-02 4 xslF345X05/form4-01022026_040103.xml 0001824280-26-000001 4817
2025-12-03 4 xslF345X05/form4-12032025_041212.xml 0001650126-25-000005 5359
2025-12-03 4 xslF345X05/form4-12032025_041210.xml 0001824280-25-000007 5368
2025-11-21 4 xslF345X05/form4-11222025_021158.xml 0001315797-25-000007 8762
2025-11-21 SCHEDULE 13D/A xslSCHEDULE_13D_X01/primary_doc.xml 0000895345-25-000365 005-91583 251509344 34 7020
2025-11-19 4 xslF345X05/form4-11192025_091101.xml 0001315797-25-000006 10883
2025-11-14 8-K 8-K 1.01,8.01,9.01 0001193125-25-283191 001-39402 251487491 34 591414 1 1
2025-11-13 424B5 424B5 0001193125-25-280384 333-278246 251479405 33 630235
2025-11-12 424B5 424B5 0001193125-25-277669 333-278246 251473097 33 632148
2025-11-10 10-Q 10-Q 0001193125-25-274240 001-39402 251466288 34 9395720 1 1
2025-11-10 8-K 8-K 2.02,9.01 0001193125-25-274220 001-39402 251466225 34 436682 1 1
2025-11-05 SCHEDULE 13G/A xslSCHEDULE_13G_X01/primary_doc.xml 0000315066-25-002688 005-91583 251452562 34 11498
2025-10-31 4 xslF345X05/form4-10312025_041004.xml 0001824280-25-000006 5367
2025-10-30 SCHEDULE 13G xslSCHEDULE_13G_X01/primary_doc.xml 0000102909-25-000068 005-91583 251434275 34 6186
2025-10-02 4 xslF345X05/form4-10022025_081058.xml 0001824280-25-000005 5368
2025-09-04 4 xslF345X05/form4-09042025_040906.xml 0001415889-25-023679 5369
2025-08-14 10-Q 10-Q 0000950170-25-108869 001-39402 251219086 34 9092701 1 1
2025-08-14 8-K 8-K 2.02,9.01 0000950170-25-108859 001-39402 251218995 34 442911 1 1
2025-08-14 SCHEDULE 13G/A xslSCHEDULE_13G_X01/primary_doc.xml 0000935836-25-000520 005-91583 251216875 34 19067
2025-08-06 SCHEDULE 13G/A xslSCHEDULE_13G_X01/primary_doc.xml 0000315066-25-001961 005-91583 251188268 34 11242
2025-08-01 4 xslF345X05/form4-08012025_040819.xml 0001415889-25-020861 5374
2025-07-16 4 xslF345X05/form4-07162025_040706.xml 0001415889-25-019838 5383
2025-07-16 4 xslF345X05/form4-07162025_040704.xml 0001415889-25-019837 5328
2025-07-16 4 xslF345X05/form4-07162025_040701.xml 0001415889-25-019836 5390
2025-07-14 144 xsl144X01/primary_doc.xml 0001959173-25-004568 001-39402 251121695 33 4504
2025-07-14 144 xsl144X01/primary_doc.xml 0001959173-25-004565 001-39402 251121577 33 4518
2025-07-14 144 xsl144X01/primary_doc.xml 0001959173-25-004563 001-39402 251121556 33 4470
2025-07-01 4 xslF345X05/form4-07012025_080710.xml 0001415889-25-018724 5374
2025-06-25 8-K 8-K 3.03,9.01 0001193125-25-147005 001-39402 251074052 34 156639 1 1
2025-06-09 4 xslF345X05/form4-06092025_080622.xml 0001415889-25-016275 5618
2025-06-09 4 xslF345X05/form4-06092025_080602.xml 0001415889-25-016267 5646
2025-06-09 4 xslF345X05/form4-06092025_080605.xml 0001415889-25-016263 5646
2025-06-09 4 xslF345X05/form4-06092025_080607.xml 0001415889-25-016258 5639
2025-06-09 4 xslF345X05/form4-06092025_080652.xml 0001415889-25-016245 5639
2025-06-09 4 xslF345X05/form4-06092025_080648.xml 0001415889-25-016243 5612
2025-06-09 4 xslF345X05/form4-06092025_080604.xml 0001415889-25-016240 5636
2025-06-09 8-K 8-K 5.07 0001193125-25-137810 001-39402 251034052 34 149777 1 1
2025-05-15 SCHEDULE 13G/A xslSCHEDULE_13G_X01/primary_doc.xml 0000902664-25-002372 005-91583 25952111 34 12190
2025-05-12 10-Q 10-Q 0000950170-25-069200 001-39402 25934894 34 8090909 1 1
2025-05-12 8-K 8-K 2.02,9.01 0000950170-25-069156 001-39402 25934688 34 394099 1 1
2025-04-30 SCHEDULE 13G/A xslSCHEDULE_13G_X01/primary_doc.xml 0000932471-25-000424 005-91583 25891884 34 6293
2025-04-28 SCHEDULE 13G xslSCHEDULE_13G_X01/primary_doc.xml 0000935836-25-000295 005-91583 25882166 34 20141
2025-04-23 ARS ARS 0001140361-25-015180 001-39402 25861370 34 2852926
2025-04-23 DEFA14A DEFA 14A 0001140361-25-015178 001-39402 25861355 34 1257062
2025-04-23 DEF 14A DEF 14A 0001140361-25-015175 001-39402 25861338 34 4833342 1 1
2025-03-03 S-8 S-8 0001193125-25-044233 333-285514 25699183 33 75845
2025-03-03 4 xslF345X05/form4-03032025_090332.xml 0001415889-25-006196 7470
2025-03-03 4 xslF345X05/form4-03032025_090331.xml 0001415889-25-006195 7404
2025-03-03 4 xslF345X05/form4-03032025_090309.xml 0001415889-25-006193 7399
2025-03-03 4 xslF345X05/form4-03032025_090314.xml 0001415889-25-006192 5612
2025-03-03 4 xslF345X05/form4-03032025_090340.xml 0001415889-25-006191 7454
2025-03-03 4 xslF345X05/form4-03032025_090336.xml 0001415889-25-006190 7462
2025-03-03 10-K 10-K 0000950170-25-030849 001-39402 25697978 34 13839809 1 1
2025-03-03 8-K 8-K 2.02,9.01 0000950170-25-030824 001-39402 25697741 34 424029 1 1
2025-02-20 4 xslF345X05/form4-02202025_090205.xml 0001415889-25-004891 5340
2025-02-20 4 xslF345X05/form4-02202025_090227.xml 0001415889-25-004889 5406
2025-02-20 4 xslF345X05/form4-02202025_090206.xml 0001415889-25-004888 5390
2025-02-20 4 xslF345X05/form4-02202025_090246.xml 0001415889-25-004887 5396
2025-02-20 4 xslF345X05/form4-02202025_090202.xml 0001415889-25-004886 5333
2025-02-18 4 xslF345X05/form4-02182025_040207.xml 0001415889-25-004434 5376
2025-02-18 4 xslF345X05/form4-02182025_040205.xml 0001415889-25-004433 5334
2025-02-18 4 xslF345X05/form4-02182025_040201.xml 0001415889-25-004431 5396
2025-02-18 4 xslF345X05/form4-02182025_040203.xml 0001415889-25-004432 5391
2025-02-18 144 xsl144X01/primary_doc.xml 0001959173-25-001069 001-39402 25634519 33 5155
2025-02-18 144 xsl144X01/primary_doc.xml 0001959173-25-001067 001-39402 25634499 33 5124
2025-02-18 144 xsl144X01/primary_doc.xml 0001959173-25-001066 001-39402 25634497 33 4533
2025-02-18 144 xsl144X01/primary_doc.xml 0001959173-25-001064 001-39402 25634486 33 4481
2025-02-18 144 xsl144X01/primary_doc.xml 0001959173-25-001063 001-39402 25634478 33 5181
2025-02-14 SCHEDULE 13G/A xslSCHEDULE_13G_X01/primary_doc.xml 0000950170-25-020417 005-91583 25623275 34 139411
2025-02-13 144 xsl144X01/primary_doc.xml 0001959173-25-000953 001-39402 25619711 33 4514
2025-02-13 144 xsl144X01/primary_doc.xml 0001959173-25-000952 001-39402 25619680 33 4582
2025-02-13 144 xsl144X01/primary_doc.xml 0001959173-25-000951 001-39402 25619676 33 4482
2025-02-13 144 xsl144X01/primary_doc.xml 0001959173-25-000950 001-39402 25619640 33 4529
2025-01-31 SCHEDULE 13G xslSCHEDULE_13G_X01/primary_doc.xml 0000932471-25-000294 005-91583 25576872 34 6212
2025-01-13 8-K 8-K 8.01,9.01 0001193125-25-005009 001-39402 25524908 34 182495 1 1
2025-01-10 4 xslF345X05/form4-01102025_110119.xml 0001415889-25-001308 5577
2025-01-10 3 xslF345X02/form3-01102025_110110.xml 0001415889-25-001307 11470
2025-01-10 8-K 8-K 5.02,7.01,9.01 0001193125-25-004133 001-39402 25520539 34 176116 1 1
2025-01-08 4 xslF345X05/form4-01082025_100151.xml 0001415889-25-001149 7079
2024-12-19 S-8 S-8 0001193125-24-282050 333-283944 241563805 33 70480
2024-12-16 8-K 8-K 8.01,9.01 0001193125-24-279038 001-39402 241550150 34 186266 1 1
2024-12-06 SCHEDULE 13G/A xslSCHEDULE_13G_X01/primary_doc.xml 0000315066-24-002977 005-91583 241531146 34 11527
2024-12-04 4 xslF345X05/form4-12042024_111242.xml 0001415889-24-028316 5382
2024-11-14 SC 13G/A SC 13G/A 0001193125-24-258974 005-91583 241465194 34 50460
2024-11-14 SC 13G/A annx13ga2.htm 0000935836-24-000726 005-91583 241465082 34 61174
2024-11-14 SC 13G/A SC 13G/A 0001193125-24-258814 005-91583 241464579 34 94222
2024-11-14 SC 13G/A AMENDMENT NO. 3 TO SCHEDULE 13G 0000921895-24-002731 005-91583 241463445 34 280580
2024-11-14 10-Q 10-Q 0000950170-24-127057 001-39402 241462199 34 7597586 1 1
2024-11-14 8-K 8-K 2.02,9.01 0000950170-24-127027 001-39402 241461805 34 373106 1 1
2024-11-14 SC 13G/A annx13gasep24.txt 0000080255-24-001462 005-91583 34 6691
2024-11-12 SC 13G/A filing.txt 0000315066-24-002622 005-91583 241444401 34 8168
2024-11-12 SC 13G/A ANNEXON, INC. 0000902664-24-006422 005-91583 241444288 34 73371
2024-11-08 SC 13G us03589w1027_110824.txt 0002012383-24-003647 005-91583 241439792 34 13688
2024-11-01 4 xslF345X05/form4-11012024_041101.xml 0001415889-24-025902 10441
2024-10-22 SC 13G us03589w1027_102224.txt 0002012383-24-001659 005-91583 241387356 34 13676
2024-10-22 8-K 8-K 8.01,9.01 0001193125-24-240585 001-39402 241384456 34 182970 1 1
2024-10-17 4 xslF345X05/form4-10172024_091004.xml 0001415889-24-025382 8544
2024-10-15 144 xsl144X01/primary_doc.xml 0001959173-24-007018 001-39402 241371270 33 7670
2024-10-02 4 xslF345X05/form4-10022024_041010.xml 0001415889-24-024384 5383
2024-09-27 S-8 S-8 0001193125-24-227361 333-282360 241330600 33 67042
2024-09-20 4 xslF345X05/form4-09202024_040902.xml 0001415889-24-023771 5527
2024-09-19 144 xsl144X01/primary_doc.xml 0001959173-24-006606 001-39402 241309710 33 7025
2024-09-16 4 xslF345X05/form4-09162024_040901.xml 0001415889-24-023441 5530
2024-09-12 144 xsl144X01/primary_doc.xml 0001959173-24-006432 001-39402 241294119 33 6384
2024-09-06 4 xslF345X05/form4-09062024_040902.xml 0001415889-24-023018 5531
2024-09-05 144 xsl144X01/primary_doc.xml 0001959173-24-006250 001-39402 241280269 33 5741
2024-09-04 4 xslF345X05/form4-09042024_040906.xml 0001415889-24-022785 5382
2024-08-30 4 xslF345X05/form4-08302024_100809.xml 0001415889-24-022645 5531
2024-08-29 144 xsl144X01/primary_doc.xml 0001959173-24-006056 001-39402 241262171 33 5099
2024-08-15 EFFECT xslEFFECTX01/primary_doc.xml S-3,,2024-08-15 16:00:00 9999999995-24-002549 333-281493 241214026 33 1771
2024-08-13 CORRESP filename1.htm 0001193125-24-199857 8070
2024-08-13 UPLOAD filename1.pdf 0000000000-24-009233 333-281493 40051
2024-08-12 S-3 S-3 0001193125-24-198959 333-281493 241197724 33 303397
2024-08-12 10-Q 10-Q 0000950170-24-095401 001-39402 241196727 34 7419635 1 1
2024-08-12 8-K 8-K 2.02,9.01 0000950170-24-095073 001-39402 241194793 34 363979 1 1
2024-08-05 4 xslF345X05/form4-08052024_110859.xml 0001415889-24-020789 5383
2024-08-05 8-K 8-K 8.01,9.01 0001193125-24-193404 001-39402 241173171 34 185642 1 1
2024-07-17 4 xslF345X05/form4-07172024_080750.xml 0001415889-24-019679 5578
2024-07-17 4 xslF345X05/form4-07172024_080740.xml 0001415889-24-019678 5516
2024-07-17 4 xslF345X05/form4-07172024_080745.xml 0001415889-24-019677 6075
2024-07-15 144 xsl144X01/primary_doc.xml 0001959173-24-004905 001-39402 241117177 33 4526
2024-07-15 144 xsl144X01/primary_doc.xml 0001959173-24-004903 001-39402 241117127 33 4513
2024-07-15 144 xsl144X01/primary_doc.xml 0001959173-24-004902 001-39402 241117124 33 4477
2024-07-02 4 xslF345X05/form4-07022024_090733.xml 0001415889-24-018985 5375
2024-06-25 8-K 8-K 8.01,9.01 0001193125-24-167962 001-39402 241069902 34 190361 1 1
2024-06-12 8-K 8-K 5.07 0001193125-24-159748 001-39402 241037918 34 157404 1 1
2024-06-07 4 xslF345X05/form4-06082024_010649.xml 0001415889-24-016111 5490
2024-06-07 4 xslF345X05/form4-06082024_010634.xml 0001415889-24-016106 5653
2024-06-07 4 xslF345X05/form4-06082024_010637.xml 0001415889-24-016105 5646
2024-06-07 4 xslF345X05/form4-06082024_010625.xml 0001415889-24-016104 5653
2024-06-07 4 xslF345X05/form4-06082024_010632.xml 0001415889-24-016103 5646
2024-06-07 4 xslF345X05/form4-06082024_010641.xml 0001415889-24-016102 5643
2024-06-07 8-K 8-K 1.01,8.01,9.01 0001193125-24-157454 001-39402 241030256 34 584874 1 1
2024-06-07 424B5 424B5 0001193125-24-156429 333-278246 241027108 33 630794
2024-06-06 FWP FWP 0001193125-24-155354 333-278246 241023562 34 83780
2024-06-05 4 xslF345X05/form4-06052024_080641.xml 0001415889-24-015560 5377
2024-06-04 424B5 424B5 0001193125-24-154391 333-278246 241019504 33 590203
2024-06-04 8-K 8-K 7.01,8.01,9.01 0001193125-24-153625 001-39402 241016063 34 16796857 1 1
2024-05-13 10-Q 10-Q 0000950170-24-058659 001-39402 24939147 34 6325838 1 1
2024-05-13 8-K 8-K 2.02,9.01 0000950170-24-058629 001-39402 24938977 34 335528 1 1
2024-05-07 8-K 8-K 8.01,9.01 0001193125-24-133086 001-39402 24921732 34 188639 1 1
2024-05-03 4 xslF345X05/form4-05032024_040501.xml 0001415889-24-012154 5376
2024-04-25 ARS ARS 0001140361-24-022040 001-39402 24876291 34 2371431
2024-04-25 DEFA14A DEFA14A 0001140361-24-022034 001-39402 24876220 34 959074
2024-04-25 DEF 14A DEF 14A 0001140361-24-022025 001-39402 24876135 34 2587053
2024-04-22 SC 13G SC 13G 0001193125-24-105483 005-91583 24862481 34 61606
2024-04-10 4 xslF345X05/form4-04102024_110457.xml 0001415889-24-010667 5376
2024-04-05 424B5 424B5 0001193125-24-088458 333-278246 24826520 33 209338
2024-04-01 EFFECT xslEFFECTX01/primary_doc.xml S-3,,2024-04-01 16:00:00 9999999995-24-000818 333-278246 24812082 33 1770
2024-03-28 CORRESP filename1.htm 0001193125-24-080584 7388
2024-03-28 UPLOAD filename1.pdf 0000000000-24-003343 333-278246 40295
2024-03-26 S-3 S-3 0001193125-24-077697 333-278246 24784544 33 1422182
2024-03-26 S-8 S-8 0001193125-24-077688 333-278244 24784493 33 78572
2024-03-26 10-K 10-K 0000950170-24-036408 001-39402 24783620 34 10237184 1 1
2024-03-26 8-K 8-K 2.02,9.01 0000950170-24-036399 001-39402 24783510 34 366937 1 1
2024-03-04 8-K 8-K 7.01,9.01 0001193125-24-058031 001-39402 24716098 34 23935645 1 1
2024-02-21 4 xslF345X05/form4-02212024_040249.xml 0001415889-24-004629 5609
2024-02-21 4 xslF345X05/form4-02212024_040231.xml 0001415889-24-004627 7404
2024-02-21 4 xslF345X05/form4-02212024_040220.xml 0001415889-24-004626 7469
2024-02-21 4 xslF345X05/form4-02212024_040210.xml 0001415889-24-004623 9583
2024-02-21 4 xslF345X05/form4-02212024_040217.xml 0001415889-24-004625 10324
2024-02-21 4 xslF345X05/form4-02212024_040214.xml 0001415889-24-004624 9646
2024-02-20 144 xsl144X01/primary_doc.xml 0001959173-24-001164 001-39402 24652876 33 5011
2024-02-20 144 xsl144X01/primary_doc.xml 0001959173-24-001162 001-39402 24652865 33 4969
2024-02-20 144 xsl144X01/primary_doc.xml 0001959173-24-001161 001-39402 24652864 33 5022
2024-02-14 SC 13G/A SC 13G/A 0001104659-24-024224 005-91583 24641692 34 245306
2024-02-14 4 xslF345X05/form4-02152024_120202.xml 0001415889-24-003857 5685
2024-02-14 4 xslF345X05/form4-02152024_120225.xml 0001415889-24-003856 5705
2024-02-14 4 xslF345X05/form4-02152024_120234.xml 0001415889-24-003855 5434
2024-02-14 4 xslF345X05/form4-02152024_120219.xml 0001415889-24-003854 6175
2024-02-14 SC 13G/A SC 13G/A 0001104659-24-023958 005-91583 24640013 34 138821
2024-02-14 SC 13G/A SC 13G/A 0001104659-24-023784 005-91583 24638926 34 108394
2024-02-14 SC 13G/A SC 13G/A 0001104659-24-023528 005-91583 24637076 34 121272
2024-02-14 SC 13G/A SC 13G/A 0001580642-24-000989 005-91583 24635112 34 56021
2024-02-14 SC 13G/A AMENDMENT NO. 2 TO SCHEDULE 13G 0000921895-24-000462 005-91583 24633704 34 276592
2024-02-13 SC 13G/A annx13ga.htm 0000935836-24-000152 005-91583 24631114 34 61340
2024-02-13 SC 13G/A SC 13G/A 0001193125-24-034110 005-91583 24630926 34 98578
2024-02-12 SC 13G ANNEXON, INC. 0000902664-24-001430 005-91583 24620315 34 83938
2024-02-12 144 xsl144X01/primary_doc.xml 0001959173-24-000905 001-39402 24619641 33 4374
2024-02-12 144 xsl144X01/primary_doc.xml 0001959173-24-000903 001-39402 24619616 33 4430
2024-02-12 144 xsl144X01/primary_doc.xml 0001959173-24-000902 001-39402 24619612 33 4323
2024-02-12 144 xsl144X01/primary_doc.xml 0001959173-24-000900 001-39402 24619598 33 4362
2024-02-07 SC 13G/A ANNEXON, INC. 0000902664-24-001127 005-91583 24602099 34 100524
2024-01-23 4/A FORM 4/A SUBMISSION 0001209191-24-002080 12518
2024-01-23 4 FORM 4 SUBMISSION 0001209191-24-002074 5621
2024-01-23 4 FORM 4 SUBMISSION 0001209191-24-002072 5556
2024-01-10 SC 13G filing.txt 0000315066-24-000027 005-91583 24524977 34 8161
2024-01-08 8-K 8-K 7.01,9.01 0001193125-24-004387 001-39402 24520157 34 188790 1 1
2023-12-29 4 FORM 4 SUBMISSION 0001209191-23-059988 13145
2023-12-28 4 FORM 4 SUBMISSION 0001209191-23-059911 6156
2023-12-27 144 xsl144X01/primary_doc.xml 0001968582-23-000860 001-39402 231518503 33 4436
2023-12-22 8-K/A 8-K/A 1.01,8.01,9.01 0001193125-23-302246 001-39402 231510912 34 251092 1 1
2023-12-21 8-K 8-K 1.01,8.01,9.01 0001193125-23-301190 001-39402 231505395 34 551592 1 1
2023-12-21 424B5 424B5 0001193125-23-301183 333-258863 231505351 33 625398
2023-12-20 FWP FWP 0001193125-23-300043 333-258863 231502209 34 29211
2023-12-20 8-K 8-K 7.01,8.01,9.01 0001193125-23-300035 001-39402 231502152 34 3106869 1 1
2023-11-13 8-K 8-K 2.02,9.01 0000950170-23-062943 001-39402 231398772 34 418758 1 1
2023-11-13 10-Q 10-Q 0000950170-23-062913 001-39402 231398597 34 7801343 1 1
2023-10-24 8-K 8-K 8.01,9.01 0001193125-23-261704 001-39402 231343003 34 170950 1 1
2023-10-11 8-K 8-K 8.01,9.01 0001193125-23-254189 001-39402 231321092 34 174145 1 1
2023-08-08 SC 13G/A form1271.htm 0001623632-23-000958 005-91583 231149502 34 286160
2023-08-07 8-K 8-K 2.02,9.01 0000950170-23-039072 001-39402 231147738 34 457411 1 1
2023-08-07 10-Q 10-Q 0000950170-23-039054 001-39402 231147631 34 8363027 1 1
2023-08-02 4 xslF345X05/form4.xml 0001610717-23-000220 5232
2023-08-02 3 FORM 3 0001567619-23-006728 10472
2023-07-31 8-K 8-K 7.01,8.01,9.01 0001193125-23-199158 001-39402 231127731 34 205153 1 1
2023-07-13 144 xsl144X01/primary_doc.xml 0001959173-23-002407 001-39402 231086695 33 4245
2023-07-13 144 xsl144X01/primary_doc.xml 0001959173-23-002406 001-39402 231086677 33 4288
2023-07-13 144 xsl144X01/primary_doc.xml 0001959173-23-002404 001-39402 231086662 33 4296
2023-06-22 SC 13G annexon13g.htm 0000935836-23-000473 005-91583 231032566 34 60897
2023-06-12 4 xslF345X04/form4.xml 0001610717-23-000152 5233
2023-06-12 4 xslF345X04/form4.xml 0001610717-23-000144 5052
2023-06-12 4 xslF345X04/form4.xml 0001610717-23-000143 5200
2023-06-12 4 xslF345X04/form4.xml 0001610717-23-000142 5207
2023-06-12 4 xslF345X04/form4.xml 0001610717-23-000141 5216
2023-06-12 4 xslF345X04/form4.xml 0001610717-23-000140 5208
2023-06-09 8-K 8-K 5.07 0001193125-23-164462 001-39402 231005459 34 157304 1 1
2023-05-30 3 FORM 3 SUBMISSION 0000899243-23-014140 14632
2023-05-30 4 FORM 4 SUBMISSION 0000899243-23-014139 12818
2023-05-30 SC 13G/A SC 13G/A 0001193125-23-156689 005-91583 23977453 34 96923
2023-05-25 8-K 8-K 8.01,9.01 0001193125-23-153420 001-39402 23955906 34 223539 1 1
2023-05-08 8-K 8-K 2.02,9.01 0000950170-23-018810 001-39402 23897843 34 407801 1 1
2023-05-08 10-Q 10-Q 0000950170-23-018797 001-39402 23897756 34 7792509 1 1
2023-04-25 ARS ARS 0001140361-23-020196 001-39402 23844928 34 3827638
2023-04-25 DEFA14A DEFA14A 0001140361-23-020194 001-39402 23844901 34 9900787
2023-04-25 DEF 14A DEF 14A 0001140361-23-020189 001-39402 23844842 34 2462674
2023-03-27 3 xslF345X02/form3.xml 0001140361-23-014049 22711
2023-03-13 8-K 8-K 8.01 0001193125-23-067918 001-39402 23725389 34 146238 1 1
2023-03-06 S-8 S-8 0001193125-23-061565 333-270307 23709875 33 101274
2023-03-06 8-K 8-K 2.02,9.01 0000950170-23-006240 001-39402 23709018 34 460316 1 1
2023-03-06 10-K 10-K 0000950170-23-006232 001-39402 23708938 34 13396722 1 1
2023-02-27 SC 13G ANNEXON, INC. 0001104659-23-025996 005-91583 23674656 34 146836
2023-02-21 4 FORM 4 0001567619-23-003427 5509
2023-02-21 4 FORM 4 0001567619-23-003425 7408
2023-02-21 4 FORM 4 0001567619-23-003424 7324
2023-02-17 4 FORM 4 0001567619-23-003317 5597
2023-02-17 SC 13D/A ff1779507_13da1_satter.htm 0000895345-23-000169 005-91583 23642354 34 66321
2023-02-15 4 FORM 4 0001567619-23-003095 7082
2023-02-15 4 FORM 4 0001567619-23-003094 6994
2023-02-14 4 FORM 4 0001567619-23-002932 6019
2023-02-14 SC 13G/A SC 13G/A 0001104659-23-021648 005-91583 23629625 34 103918
2023-02-14 SC 13G/A SC 13G/A 0001104659-23-021603 005-91583 23629094 34 279064
2023-02-14 SC 13G/A SC 13G/A 0001104659-23-021434 005-91583 23628178 34 119976
2023-02-14 SC 13G/A SC 13G/A 0001580642-23-000866 005-91583 23626601 34 58506
2023-02-14 SC 13G/A SC 13G/A 0001193125-23-037026 005-91583 23622131 34 96191
2023-02-14 SC 13G/A SEC SCHEDULE 13G 0001532155-23-000063 005-91583 23620974 34 18102
2023-02-14 SC 13G/A AMENDMENT NO. 1 TO THE SCHEDULE 13G 0000921895-23-000470 005-91583 23620556 34 276941
2023-02-09 SC 13G/A ANNEXON, INC. 0000902664-23-001364 005-91583 23605057 34 105173
2023-02-03 SC 13G SC 13G 0001193125-23-023715 005-91583 23584519 34 34591
2023-02-01 SC 13G/A form816.htm 0001623632-23-000209 005-91583 23575083 34 212864
2023-01-18 4 FORM 4 0001567619-23-000998 5601
2023-01-12 3 FORM 3 0001567619-23-000893 15489
2023-01-09 8-K 8-K 7.01,8.01,9.01 0001193125-23-004050 001-39402 23516416 34 31599667 1 1
2023-01-06 8-K 8-K 5.02,7.01,9.01 0001193125-23-002932 001-39402 23513718 34 167167 1 1
2022-11-16 EFFECT xslEFFECTX01/primary_doc.xml S-3,,2022-11-16 16:00:00 9999999995-22-003316 333-268181 221396744 33 1722
2022-11-16 424B3 424B3 0001193125-22-286797 333-268181 221395472 33 208539
2022-11-14 CORRESP filename1.htm 0001193125-22-284558 7457
2022-11-10 UPLOAD filename1.pdf 0000000000-22-012264 40200
2022-11-04 S-3 S-3 0001193125-22-277977 333-268181 221362879 33 311981
2022-11-03 8-K 8-K 2.02,9.01 0000950170-22-021512 001-39402 221356062 34 484783 1 1
2022-11-03 10-Q 10-Q 0000950170-22-021509 001-39402 221356057 34 8945725 1 1
2022-08-08 S-8 S-8 0001193125-22-215083 333-266671 221145566 33 92778
2022-08-08 8-K 8-K 2.02,9.01 0000950170-22-015569 001-39402 221144836 34 476261 1 1
2022-08-08 10-Q 10-Q 0000950170-22-015560 001-39402 221144767 34 8607763 1 1
2022-07-22 D xslFormDX01/primary_doc.xml 06b 0001567619-22-014328 021-453365 221098882 33 14674
2022-07-18 SC 13G/A SC 13G/A 0001104659-22-080557 005-91583 221089854 34 103412
2022-07-18 SC 13D ff0001145861_13d-satter.htm 0000895345-22-000552 005-91583 221089621 34 120389
2022-07-18 SC 13G ANNEXON, INC. 0000902664-22-003634 005-91583 221089488 34 113836
2022-07-13 4 FORM 4 0001567619-22-013999 7392
2022-07-13 4 FORM 4 0001567619-22-013998 5500
2022-07-13 4 FORM 4 0001567619-22-013997 7394
2022-07-13 4 FORM 4 0001567619-22-013996 7394
2022-07-13 4 FORM 4 0001567619-22-013994 5500
2022-07-13 4 FORM 4 0001567619-22-013992 5500
2022-07-13 4 FORM 4 0001567619-22-013991 7305
2022-07-11 4 FORM 4 0001567619-22-013890 8685
2022-07-08 8-K 8-K 1.01,3.02,8.01,9.01 0001193125-22-190590 001-39402 221075306 34 19342390 1 1
2022-07-08 SC 13G us03589w1027_070822.txt 0000834237-22-010202 005-91583 221074955 34 12214
2022-06-23 SC 13G SC 13G 0001104659-22-073896 005-91583 221035462 34 302511
2022-06-13 4 FORM 4 0001567619-22-012781 5389
2022-06-13 4 FORM 4 0001567619-22-012780 5550
2022-06-13 4 FORM 4 0001567619-22-012779 5557
2022-06-13 4 FORM 4 0001567619-22-012777 5540
2022-06-13 4 FORM 4 0001567619-22-012775 5537
2022-06-13 4 FORM 4 0001567619-22-012774 5545
2022-06-10 8-K 8-K 5.07 0001193125-22-171932 001-39402 221008872 34 156854 1 1
2022-06-07 8-K 8-K 8.01,9.01 0001193125-22-169265 001-39402 221001282 34 186931 1 1
2022-05-26 SC 13G THE SCHEDULE 13G 0000921895-22-001808 005-91583 22971230 34 284171
2022-05-09 8-K 8-K 2.02,9.01 0000950170-22-008510 001-39402 22905304 34 568332 1 1
2022-05-09 10-Q 10-Q 0000950170-22-008494 001-39402 22905043 34 7275716 1 1
2022-05-03 EFFECT xslEFFECTX01/primary_doc.xml POS AM,0001193125-22-061775,2022-05-03 9999999995-22-001281 333-258863 22889643 33 1732
2022-05-03 POS EX POS EX 0001193125-22-138660 333-258863 22886748 33 54079
2022-04-27 DEFA14A DEFA14A 0001140361-22-016235 001-39402 22859762 34 1784521
2022-04-27 DEF 14A DEF 14A 0001140361-22-016231 001-39402 22859721 34 2072040
2022-04-21 SC 13G SC 13G 0001104659-22-048153 005-91583 22839963 34 93877
2022-04-18 4 FORM 4 0001567619-22-008630 5344
2022-04-07 8-K 8-K 8.01,9.01 0001193125-22-099060 001-39402 22814742 34 165158 1 1
2022-03-02 POS AM POS AM 0001193125-22-061775 333-258863 22700428 33 520874
2022-03-02 S-8 S-8 0001193125-22-061764 333-263193 22700398 33 113051
2022-03-01 8-K 8-K 2.02,9.01 0001564590-22-008052 001-39402 22698363 34 597138 1 1
2022-03-01 10-K 10-K 0001564590-22-008044 001-39402 22698218 34 13161482 1 1
2022-03-01 POSASR POSASR 0001193125-22-061274 333-258863 22697824 33 586907
2022-02-22 8-K 8-K 8.01 0001193125-22-048725 001-39402 22659463 34 151505 1 1
2022-02-15 4 FORM 4 0001567619-22-004615 7389
2022-02-15 4 FORM 4 0001567619-22-004614 7413
2022-02-15 4 FORM 4 0001567619-22-004613 7406
2022-02-15 4 FORM 4 0001567619-22-004612 7326
2022-02-15 4 FORM 4 0001567619-22-004611 7415
2022-02-14 SC 13G/A SC 13G/A 0001104659-22-023129 005-91583 22634468 34 73700
2022-02-14 SC 13G Annexon.htm 0001532155-22-000053 005-91583 22630934 34 18148
2022-02-14 SC 13G annx13gdec21.txt 0000080255-22-002239 005-91583 34 6829
2022-02-14 SC 13G form36.htm 0001623632-22-000235 005-91583 22628930 34 278098
2022-02-14 SC 13G/A SC 13G/A 0001580642-22-000823 005-91583 22627461 34 61501
2022-02-14 SC 13G/A ANNEXON, INC. 0001104659-22-021208 005-91583 22624697 34 139951
2022-02-11 SC 13G/A SC 13G/A 0001104659-22-020554 005-91583 22621597 34 72395
2022-02-10 SC 13G SC 13G 0001193125-22-033921 005-91583 22612117 34 34645
2022-02-09 SC 13G/A filing.txt 0000315066-22-000789 005-91583 22604084 34 8513
2022-02-03 SC 13G/A us03589w1027_020322.txt 0000834237-22-006307 005-91583 22589040 34 13256
2022-02-03 8-K 8-K 5.02 0001193125-22-026977 001-39402 22588287 34 145176 1 1
2022-01-20 4 FORM 4 0001567619-22-001370 5505
2022-01-20 3 FORM 3 0001567619-22-001369 11629
2022-01-20 8-K 8-K 5.02,7.01,9.01 0001193125-22-013774 001-39402 22542372 34 175570 1 1
2022-01-10 8-K 8-K 7.01,9.01 0001193125-22-005010 001-39402 22519600 34 12076384 1 1
2022-01-04 8-K 8-K 8.01,9.01 0001193125-22-001705 001-39402 22506106 34 183002 1 1

Latest XBRL company facts

One latest value per concept from companyfacts (258 concepts). Full history stays in the JSON.

TaxonomyTagLabelUnitValueStartEndFYFPFormFiledAccn
dei EntityCommonStockSharesOutstanding Entity Common Stock, Shares Outstanding shares 38.56M 2022-05-02 2022 Q1 10-Q 2022-05-09 0000950170-22-008494
dei EntityPublicFloat Entity Public Float USD 244.40M 2025-06-30 2025 FY 10-K 2026-03-30 0001193125-26-131782
ecd NonPeoNeoAvgCompActuallyPaidAmt NonPeoNeoAvgCompActuallyPaidAmt USD 1.73M 2025-01-01 2025-12-31 DEF 14A 2026-04-27 0001140361-26-017085
ecd NonPeoNeoAvgTotalCompAmt NonPeoNeoAvgTotalCompAmt USD 1.36M 2025-01-01 2025-12-31 DEF 14A 2026-04-27 0001140361-26-017085
ecd PeoActuallyPaidCompAmt PeoActuallyPaidCompAmt USD 5.08M 2025-01-01 2025-12-31 DEF 14A 2026-04-27 0001140361-26-017085
ecd PeoTotalCompAmt PeoTotalCompAmt USD 3.58M 2025-01-01 2025-12-31 DEF 14A 2026-04-27 0001140361-26-017085
ecd TotalShareholderRtnAmt TotalShareholderRtnAmt USD 20.06 2025-01-01 2025-12-31 DEF 14A 2026-04-27 0001140361-26-017085
us-gaap AccountsPayableCurrent Accounts Payable, Current USD 15.91M 2026-09-30 2026 Q3 10-Q 2026-11-09 0001193125-26-453585
us-gaap AccretionAmortizationOfDiscountsAndPremiumsInvestments Accretion (Amortization) of Discounts and Premiums, Investments USD 1.48M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-09 0001193125-26-453585
us-gaap AccruedLiabilitiesCurrent Accrued Liabilities, Current USD 10.66M 2024-06-30 2024 Q2 10-Q 2024-08-12 0000950170-24-095401
us-gaap AccruedProfessionalFeesCurrent Accrued Professional Fees, Current USD 656,000 2026-09-30 2026 Q3 10-Q 2026-11-09 0001193125-26-453585
us-gaap AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment USD 10.95M 2026-09-30 2026 Q3 10-Q 2026-11-09 0001193125-26-453585
us-gaap AccumulatedOtherComprehensiveIncomeLossNetOfTax Accumulated Other Comprehensive Income (Loss), Net of Tax USD -154,000 2026-09-30 2026 Q3 10-Q 2026-11-09 0001193125-26-453585
us-gaap AdditionalPaidInCapital Additional Paid in Capital USD 1.21B 2026-09-30 2026 Q3 10-Q 2026-11-09 0001193125-26-453585
us-gaap AdjustmentsToAdditionalPaidInCapitalConvertibleDebtWithConversionFeature Adjustments to Additional Paid in Capital, Convertible Debt with Conversion Feature USD 6.30M 2020-04-01 2020-06-30 2020 Q3 10-Q 2020-11-16 0001564590-20-054172
us-gaap AdjustmentsToAdditionalPaidInCapitalIncreaseInCarryingAmountOfRedeemablePreferredStock Adjustments to Additional Paid in Capital, Increase in Carrying Amount of Redeemable Preferred Stock USD 705,000 2020-01-01 2020-12-31 2021 FY 10-K 2022-03-01 0001564590-22-008044
us-gaap AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue APIC, Share-based Payment Arrangement, Increase for Cost Recognition USD 5.11M 2026-07-01 2026-09-30 2026 Q3 10-Q 2026-11-09 0001193125-26-453585
us-gaap AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts Adjustments to Additional Paid in Capital, Stock Issued, Issuance Costs USD 103,000 2026-07-01 2026-09-30 2026 Q3 10-Q 2026-11-09 0001193125-26-453585
us-gaap AdjustmentsToAdditionalPaidInCapitalWarrantIssued Adjustments to Additional Paid in Capital, Warrant Issued USD 122.49M 2022-01-01 2022-12-31 2022 FY 10-K 2023-03-06 0000950170-23-006232
us-gaap AllocatedShareBasedCompensationExpense Share-based Payment Arrangement, Expense USD 14.08M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-09 0001193125-26-453585
us-gaap AllowanceForDoubtfulAccountsReceivable Accounts Receivable, Allowance for Credit Loss USD 0 2026-09-30 2026 Q3 10-Q 2026-11-09 0001193125-26-453585
us-gaap AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount shares 25.86M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-09 0001193125-26-453585
us-gaap Assets Assets USD 250.41M 2026-09-30 2026 Q3 10-Q 2026-11-09 0001193125-26-453585
us-gaap AssetsCurrent Assets, Current USD 217.90M 2026-09-30 2026 Q3 10-Q 2026-11-09 0001193125-26-453585
us-gaap AssetsFairValueDisclosure Assets, Fair Value Disclosure USD 370.09M 2020-09-30 2020 Q3 10-Q 2020-11-16 0001564590-20-054172
us-gaap AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax Debt Securities, Available-for-sale, Accumulated Gross Unrealized Gain, before Tax USD 1,000 2026-09-30 2026 Q3 10-Q 2026-11-09 0001193125-26-453585
us-gaap AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax Debt Securities, Available-for-sale, Accumulated Gross Unrealized Loss, before Tax USD 74,000 2026-09-30 2026 Q3 10-Q 2026-11-09 0001193125-26-453585
us-gaap AvailableForSaleDebtSecuritiesAmortizedCostBasis Debt Securities, Available-for-sale, Amortized Cost USD 204.68M 2026-09-30 2026 Q3 10-Q 2026-11-09 0001193125-26-453585
us-gaap AvailableForSaleSecuritiesDebtSecurities Debt Securities, Available-for-sale USD 204.60M 2026-09-30 2026 Q3 10-Q 2026-11-09 0001193125-26-453585
us-gaap AvailableForSaleSecuritiesDebtSecuritiesCurrent Debt Securities, Available-for-sale, Current USD 110.98M 2026-09-30 2026 Q3 10-Q 2026-11-09 0001193125-26-453585
us-gaap CapitalExpendituresIncurredButNotYetPaid Capital Expenditures Incurred but Not yet Paid USD 15,000 2025-01-01 2025-03-31 2025 Q1 10-Q 2025-05-12 0000950170-25-069200
us-gaap Cash Cash USD 8.77M 2026-09-30 2026 Q3 10-Q 2026-11-09 0001193125-26-453585
us-gaap CashAndCashEquivalentsAtCarryingValue Cash and Cash Equivalents, at Carrying Value USD 102.39M 2026-09-30 2026 Q3 10-Q 2026-11-09 0001193125-26-453585
us-gaap CashAndCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect Cash and Cash Equivalents, Period Increase (Decrease), Excluding Exchange Rate Effect USD 224.63M 2020-01-01 2020-12-31 2020 FY 10-K 2021-03-25 0001564590-21-015262
us-gaap CashCashEquivalentsAndShortTermInvestments Cash, Cash Equivalents, and Short-term Investments USD 213.40M 2026-09-30 2026 Q3 10-Q 2026-11-09 0001193125-26-453585
us-gaap CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents USD 103.42M 2026-09-30 2026 Q3 10-Q 2026-11-09 0001193125-26-453585
us-gaap CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Including Disposal Group and Discontinued Operations USD 103.42M 2026-09-30 2026 Q3 10-Q 2026-11-09 0001193125-26-453585
us-gaap CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Excluding Exchange Rate Effect USD -59.66M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-09 0001193125-26-453585
us-gaap CashEquivalentsAtCarryingValue Cash Equivalents, at Carrying Value USD 93.62M 2026-09-30 2026 Q3 10-Q 2026-11-09 0001193125-26-453585
us-gaap CommonStockCapitalSharesReservedForFutureIssuance Common Stock, Capital Shares Reserved for Future Issuance shares 72.54M 2026-09-30 2026 Q3 10-Q 2026-11-09 0001193125-26-453585
us-gaap CommonStockDividendsPerShareDeclared Common Stock, Dividends, Per Share, Declared USD/shares 0 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-30 0001193125-26-131782
us-gaap CommonStockParOrStatedValuePerShare Common Stock, Par or Stated Value Per Share USD/shares 0.001 2025-12-31 2025 FY 10-K 2026-03-30 0001193125-26-131782
us-gaap CommonStockSharesAuthorized Common Stock, Shares Authorized shares 300.00M 2025-12-31 2025 FY 10-K 2026-03-30 0001193125-26-131782
us-gaap CommonStockSharesIssued Common Stock, Shares, Issued shares 149.36M 2025-12-31 2025 FY 10-K 2026-03-30 0001193125-26-131782
us-gaap CommonStockSharesOutstanding Common Stock, Shares, Outstanding shares 149.36M 2025-12-31 2025 FY 10-K 2026-03-30 0001193125-26-131782
us-gaap CommonStockValue Common Stock, Value, Issued USD 190,000 2026-09-30 2026 Q3 10-Q 2026-11-09 0001193125-26-453585
us-gaap ComprehensiveIncomeNetOfTax Comprehensive Income (Loss), Net of Tax, Attributable to Parent USD -150.83M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-09 0001193125-26-453585
us-gaap ConvertiblePreferredStockSharesIssuedUponConversion Convertible Preferred Stock, Shares Issued upon Conversion shares 20.82M 2020-07-24 2021 FY 10-K 2022-03-01 0001564590-22-008044
us-gaap DebtInstrumentCarryingAmount Long-term Debt, Gross USD 52.50M 2026-09-30 2026 Q3 10-Q 2026-11-09 0001193125-26-453585
us-gaap DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet Debt Instrument, Unamortized Discount (Premium) and Debt Issuance Costs, Net USD -3.16M 2026-09-30 2026 Q3 10-Q 2026-11-09 0001193125-26-453585
us-gaap DebtIssuanceCostsIncurredDuringNoncashOrPartialNoncashTransaction Debt Issuance Costs Incurred During Noncash or Partial Noncash Transaction USD 179,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-09 0001193125-26-453585
us-gaap DebtSecuritiesAvailableForSaleAllowanceForCreditLoss Debt Securities, Available-for-sale, Allowance for Credit Loss USD 0 2026-09-30 2026 Q3 10-Q 2026-11-09 0001193125-26-453585
us-gaap DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger Debt Securities, Available-for-sale, Continuous Unrealized Loss Position, 12 Months or Longer USD 0 2026-09-30 2026 Q3 10-Q 2026-11-09 0001193125-26-453585
us-gaap DeferredIncomeTaxLiabilities Deferred Tax Liabilities, Gross USD 4.36M 2025-12-31 2025 FY 10-K 2026-03-30 0001193125-26-131782
us-gaap DeferredOfferingCosts Deferred Offering Costs USD 2.30M 2019-12-31 2020 FY 10-K 2021-03-25 0001564590-21-015262
us-gaap DeferredRentCreditCurrent Deferred Rent Credit, Current USD 391,000 2020-12-31 2021 FY 10-K 2022-03-01 0001564590-22-008044
us-gaap DeferredRentCreditNoncurrent Deferred Rent Credit, Noncurrent USD 1.05M 2020-12-31 2021 FY 10-K 2022-03-01 0001564590-22-008044
us-gaap DeferredTaxAssetsGross Deferred Tax Assets, Gross USD 229.25M 2025-12-31 2025 FY 10-K 2026-03-30 0001193125-26-131782
us-gaap DeferredTaxAssetsInvestments Deferred Tax Assets, Investments USD 240,000 2021-12-31 2022 FY 10-K 2023-03-06 0000950170-23-006232
us-gaap DeferredTaxAssetsLiabilitiesNet Deferred Tax Assets, Net USD 0 2025-12-31 2025 FY 10-K 2026-03-30 0001193125-26-131782
us-gaap DeferredTaxAssetsNet Deferred Tax Assets, Net of Valuation Allowance USD 4.36M 2025-12-31 2025 FY 10-K 2026-03-30 0001193125-26-131782
us-gaap DeferredTaxAssetsOperatingLossCarryforwards Deferred Tax Assets, Operating Loss Carryforwards USD 133.95M 2025-12-31 2025 FY 10-K 2026-03-30 0001193125-26-131782
us-gaap DeferredTaxAssetsOperatingLossCarryforwardsDomestic Deferred Tax Assets, Operating Loss Carryforwards, Domestic USD 556.20M 2025-12-31 2025 FY 10-K 2026-03-30 0001193125-26-131782
us-gaap DeferredTaxAssetsOperatingLossCarryforwardsStateAndLocal Deferred Tax Assets, Operating Loss Carryforwards, State and Local USD 226.10M 2025-12-31 2025 FY 10-K 2026-03-30 0001193125-26-131782
us-gaap DeferredTaxAssetsTaxCreditCarryforwardsResearch Deferred Tax Assets, Tax Credit Carryforwards, Research USD 33.16M 2025-12-31 2025 FY 10-K 2026-03-30 0001193125-26-131782
us-gaap DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost Deferred Tax Assets, Tax Deferred Expense, Compensation and Benefits, Share-based Compensation Cost USD 4.81M 2025-12-31 2025 FY 10-K 2026-03-30 0001193125-26-131782
us-gaap DeferredTaxAssetsTaxDeferredExpenseReservesAndAccruals Deferred Tax Assets, Tax Deferred Expense, Reserves and Accruals USD 1.55M 2025-12-31 2025 FY 10-K 2026-03-30 0001193125-26-131782
us-gaap DeferredTaxAssetsValuationAllowance Deferred Tax Assets, Valuation Allowance USD 224.89M 2025-12-31 2025 FY 10-K 2026-03-30 0001193125-26-131782
us-gaap DeferredTaxLiabilitiesPropertyPlantAndEquipment Deferred Tax Liabilities, Property, Plant and Equipment USD 1.16M 2025-12-31 2025 FY 10-K 2026-03-30 0001193125-26-131782
us-gaap Depreciation Depreciation USD 1.60M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-09 0001193125-26-453585
us-gaap DepreciationDepletionAndAmortization Depreciation, Depletion and Amortization USD 1.60M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-09 0001193125-26-453585
us-gaap EarningsPerShareBasic Earnings Per Share, Basic USD/shares -0.75 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-09 0001193125-26-453585
us-gaap EarningsPerShareBasicAndDiluted Earnings Per Share, Basic and Diluted USD/shares -0.92 2022-01-01 2022-03-31 2022 Q1 10-Q 2022-05-09 0000950170-22-008494
us-gaap EarningsPerShareDiluted Earnings Per Share, Diluted USD/shares -0.75 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-09 0001193125-26-453585
us-gaap EffectiveIncomeTaxRateContinuingOperations Effective Income Tax Rate Reconciliation, Percent pure 0 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-30 0001193125-26-131782
us-gaap EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate Effective Income Tax Rate Reconciliation, at Federal Statutory Income Tax Rate, Percent pure 0.21 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-30 0001193125-26-131782
us-gaap EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance Effective Income Tax Rate Reconciliation, Change in Deferred Tax Assets Valuation Allowance, Percent pure -0.208 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-30 0001193125-26-131782
us-gaap EffectiveIncomeTaxRateReconciliationChangeInEnactedTaxRate Effective Income Tax Rate Reconciliation, Change in Enacted Tax Rate, Percent pure 0 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-30 0001193125-26-131782
us-gaap EffectiveIncomeTaxRateReconciliationNondeductibleExpenseOther Effective Income Tax Rate Reconciliation, Nondeductible Expense, Other, Percent pure 0 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-30 0001193125-26-131782
us-gaap EffectiveIncomeTaxRateReconciliationNondeductibleExpenseShareBasedCompensationCost Effective Income Tax Rate Reconciliation, Nondeductible Expense, Share-based Payment Arrangement, Percent pure -0.005 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-30 0001193125-26-131782
us-gaap EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes Effective Income Tax Rate Reconciliation, State and Local Income Taxes, Percent pure 0 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-30 0001193125-26-131782
us-gaap EffectiveIncomeTaxRateReconciliationTaxCreditsResearch Effective Income Tax Rate Reconciliation, Tax Credit, Research, Percent pure -0.011 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-30 0001193125-26-131782
us-gaap EffectiveIncomeTaxRateReconciliationTaxSettlementsForeign Effective Income Tax Rate Reconciliation, Tax Settlement, Foreign, Percent pure 0 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-30 0001193125-26-131782
us-gaap EffectOfExchangeRateOnCashAndCashEquivalents Effect of Exchange Rate on Cash and Cash Equivalents USD 9,000 2020-01-01 2020-12-31 2020 FY 10-K 2021-03-25 0001564590-21-015262
us-gaap EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents Effect of Exchange Rate on Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents USD 1,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-09 0001193125-26-453585
us-gaap EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions Share-based Payment Arrangement, Nonvested Award, Option, Cost Not yet Recognized, Amount USD 58.00M 2021-09-30 2021 Q3 10-Q 2021-11-09 0001564590-21-055728
us-gaap FairValueAssetsLevel1ToLevel2TransfersAmount Fair Value, Assets, Level 1 to Level 2 Transfers, Amount USD 0 2020-09-30 2020 Q3 10-Q 2020-11-16 0001564590-20-054172
us-gaap FairValueAssetsLevel2ToLevel1TransfersAmount Fair Value, Assets, Level 2 to Level 1 Transfers, Amount USD 0 2020-09-30 2020 Q3 10-Q 2020-11-16 0001564590-20-054172
us-gaap FairValueLiabilitiesLevel1ToLevel2TransfersAmount Fair Value, Liabilities, Level 1 to Level 2 Transfers, Amount USD 0 2020-09-30 2020 Q3 10-Q 2020-11-16 0001564590-20-054172
us-gaap FairValueLiabilitiesLevel2ToLevel1TransfersAmount Fair Value, Liabilities, Level 2 to Level 1 Transfers, Amount USD 0 2020-09-30 2020 Q3 10-Q 2020-11-16 0001564590-20-054172
us-gaap FairValueMeasurementWithUnobservableInputsReconciliationLiabilityTransfersIntoLevel3 Fair Value, Measurement with Unobservable Inputs Reconciliation, Liability, Transfers Into Level 3 USD 0 2020-01-01 2020-09-30 2020 Q3 10-Q 2020-11-16 0001564590-20-054172
us-gaap FairValueMeasurementWithUnobservableInputsReconciliationLiabilityTransfersOutOfLevel3 Fair Value, Measurement with Unobservable Inputs Reconciliation, Liability, Transfers out of Level 3 USD 0 2020-01-01 2020-09-30 2020 Q3 10-Q 2020-11-16 0001564590-20-054172
us-gaap FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersIntoLevel3 Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Asset Transfers Into Level 3 USD 0 2020-01-01 2020-09-30 2020 Q3 10-Q 2020-11-16 0001564590-20-054172
us-gaap FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersOutOfLevel3 Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Asset, Transfers out of Level 3 USD 0 2020-01-01 2020-09-30 2020 Q3 10-Q 2020-11-16 0001564590-20-054172
us-gaap GeneralAndAdministrativeExpense General and Administrative Expense USD 31.77M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-09 0001193125-26-453585
us-gaap ImpairmentOfLongLivedAssetsToBeDisposedOf Impairment of Long-Lived Assets to be Disposed of USD 0 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-30 0001193125-26-131782
us-gaap IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic Income (Loss) from Continuing Operations before Income Taxes, Domestic USD -206.68M 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-30 0001193125-26-131782
us-gaap IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest USD -206.69M 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-30 0001193125-26-131782
us-gaap IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign Income (Loss) from Continuing Operations before Income Taxes, Foreign USD -9,000 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-30 0001193125-26-131782
us-gaap IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments Income (Loss) from Continuing Operations before Equity Method Investments, Income Taxes, Noncontrolling Interest USD -92.95M 2021-01-01 2021-09-30 2021 Q3 10-Q 2021-11-09 0001564590-21-055728
us-gaap IncomeTaxesPaid Income Taxes Paid USD 2,000 2019-01-01 2019-12-31 2020 FY 10-K 2021-03-25 0001564590-21-015262
us-gaap IncomeTaxExpenseBenefit Income Tax Expense (Benefit) USD 0 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-30 0001193125-26-131782
us-gaap IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance Effective Income Tax Rate Reconciliation, Change in Deferred Tax Assets Valuation Allowance, Amount USD 42.88M 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-30 0001193125-26-131782
us-gaap IncomeTaxReconciliationChangeInEnactedTaxRate Effective Income Tax Rate Reconciliation, Change in Enacted Tax Rate, Amount USD 0 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-30 0001193125-26-131782
us-gaap IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate Effective Income Tax Rate Reconciliation at Federal Statutory Income Tax Rate, Amount USD -43.41M 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-30 0001193125-26-131782
us-gaap IncomeTaxReconciliationNondeductibleExpenseOther Effective Income Tax Rate Reconciliation, Nondeductible Expense, Other, Amount USD 60,000 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-30 0001193125-26-131782
us-gaap IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost Effective Income Tax Rate Reconciliation, Nondeductible Expense, Share-based Payment Arrangement, Amount USD 1.10M 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-30 0001193125-26-131782
us-gaap IncomeTaxReconciliationOtherReconcilingItems Effective Income Tax Rate Reconciliation, Other Reconciling Items, Amount USD 43,000 2024-01-01 2024-12-31 2024 FY 10-K 2025-03-03 0000950170-25-030849
us-gaap IncomeTaxReconciliationStateAndLocalIncomeTaxes Effective Income Tax Rate Reconciliation, State and Local Income Taxes, Amount USD 72,000 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-30 0001193125-26-131782
us-gaap IncomeTaxReconciliationTaxCreditsResearch Effective Income Tax Rate Reconciliation, Tax Credit, Research, Amount USD 2.24M 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-30 0001193125-26-131782
us-gaap IncomeTaxReconciliationTaxSettlementsForeign Effective Income Tax Rate Reconciliation, Tax Settlement, Foreign, Amount USD 1,000 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-30 0001193125-26-131782
us-gaap IncreaseDecreaseInAccountsPayable Increase (Decrease) in Accounts Payable USD 778,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-09 0001193125-26-453585
us-gaap IncreaseDecreaseInAccruedLiabilities Increase (Decrease) in Accrued Liabilities USD -6.28M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-09 0001193125-26-453585
us-gaap IncreaseDecreaseInOtherCurrentLiabilities Increase (Decrease) in Other Current Liabilities USD -21,000 2024-01-01 2024-06-30 2024 Q2 10-Q 2024-08-12 0000950170-24-095401
us-gaap IncreaseDecreaseInOtherDeferredLiability Increase (Decrease) in Other Deferred Liability USD -366,000 2020-01-01 2020-12-31 2021 FY 10-K 2022-03-01 0001564590-22-008044
us-gaap IncreaseDecreaseInOtherNoncurrentAssets Increase (Decrease) in Other Noncurrent Assets USD -116,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-09 0001193125-26-453585
us-gaap IncreaseDecreaseInOtherOperatingAssets Increase (Decrease) in Other Operating Assets USD 204,000 2022-01-01 2022-09-30 2023 Q3 10-Q 2023-11-13 0000950170-23-062913
us-gaap IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets Increase (Decrease) in Prepaid Expense and Other Assets USD 679,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-09 0001193125-26-453585
us-gaap IncreaseInCarryingAmountOfRedeemablePreferredStock Increase in Carrying Amount of Redeemable Preferred Stock USD 6.20M 2020-07-22 2020-07-24 2020 FY 10-K 2021-03-25 0001564590-21-015262
us-gaap InterestExpenseNonoperating InterestExpenseNonoperating USD 833,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-09 0001193125-26-453585
us-gaap InterestPaidNet Interest Paid, Excluding Capitalized Interest, Operating Activities USD 356,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-09 0001193125-26-453585
us-gaap LeaseAndRentalExpense Operating Leases, Rent Expense USD 353,000 2020-01-01 2020-12-31 2020 FY 10-K 2021-03-25 0001564590-21-015262
us-gaap LesseeOperatingLeaseLiabilityPaymentsDue Lessee, Operating Lease, Liability, to be Paid USD 29.36M 2026-09-30 2026 Q3 10-Q 2026-11-09 0001193125-26-453585
us-gaap LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths Lessee, Operating Lease, Liability, to be Paid, Year One USD 5.42M 2026-09-30 2026 Q3 10-Q 2026-11-09 0001193125-26-453585
us-gaap LesseeOperatingLeaseLiabilityPaymentsDueYearFour Lessee, Operating Lease, Liability, to be Paid, Year Four USD 5.81M 2025-12-31 2025 FY 10-K 2026-03-30 0001193125-26-131782
us-gaap LesseeOperatingLeaseLiabilityPaymentsDueYearThree Lessee, Operating Lease, Liability, to be Paid, Year Three USD 5.81M 2026-09-30 2026 Q3 10-Q 2026-11-09 0001193125-26-453585
us-gaap LesseeOperatingLeaseLiabilityPaymentsDueYearTwo Lessee, Operating Lease, Liability, to be Paid, Year Two USD 5.62M 2026-09-30 2026 Q3 10-Q 2026-11-09 0001193125-26-453585
us-gaap LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear Lessee, Operating Lease, Liability, to be Paid, Remainder of Fiscal Year USD 1.33M 2026-09-30 2026 Q3 10-Q 2026-11-09 0001193125-26-453585
us-gaap LesseeOperatingLeaseLiabilityUndiscountedExcessAmount Lessee, Operating Lease, Liability, Undiscounted Excess Amount USD 5.51M 2026-09-30 2026 Q3 10-Q 2026-11-09 0001193125-26-453585
us-gaap Liabilities Liabilities USD 107.61M 2026-09-30 2026 Q3 10-Q 2026-11-09 0001193125-26-453585
us-gaap LiabilitiesAndStockholdersEquity Liabilities and Equity USD 250.41M 2026-09-30 2026 Q3 10-Q 2026-11-09 0001193125-26-453585
us-gaap LiabilitiesCurrent Liabilities, Current USD 37.66M 2026-09-30 2026 Q3 10-Q 2026-11-09 0001193125-26-453585
us-gaap LiabilitiesFairValueAdjustment Liabilities, Fair Value Adjustment USD 0 2020-01-01 2020-12-31 2020 FY 10-K 2021-03-25 0001564590-21-015262
us-gaap LiabilitiesFairValueDisclosure Financial and Nonfinancial Liabilities, Fair Value Disclosure USD 5.14M 2018-12-31 2020 FY 10-K 2021-03-25 0001564590-21-015262
us-gaap LiabilityForUncertainTaxPositionsCurrent Liability for Uncertainty in Income Taxes, Current USD 0 2025-12-31 2025 FY 10-K 2026-03-30 0001193125-26-131782
us-gaap LongTermDebtFairValue Long-term Debt, Fair Value USD 49.30M 2026-09-30 2026 Q3 10-Q 2026-11-09 0001193125-26-453585
us-gaap LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths Long-Term Debt, Maturity, Year One USD 0 2026-09-30 2026 Q3 10-Q 2026-11-09 0001193125-26-453585
us-gaap LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive Long-Term Debt, Maturity, Year Five USD 17.72M 2026-09-30 2026 Q3 10-Q 2026-11-09 0001193125-26-453585
us-gaap LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour Long-Term Debt, Maturity, Year Four USD 26.09M 2026-09-30 2026 Q3 10-Q 2026-11-09 0001193125-26-453585
us-gaap LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree Long-Term Debt, Maturity, Year Three USD 8.70M 2026-09-30 2026 Q3 10-Q 2026-11-09 0001193125-26-453585
us-gaap LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo Long-Term Debt, Maturity, Year Two USD 0 2026-09-30 2026 Q3 10-Q 2026-11-09 0001193125-26-453585
us-gaap LongTermDebtMaturitiesRepaymentsOfPrincipalRemainderOfFiscalYear Long-Term Debt, Maturity, Remainder of Fiscal Year USD 0 2026-09-30 2026 Q3 10-Q 2026-11-09 0001193125-26-453585
us-gaap LongTermDebtNoncurrent Long-term Debt, Excluding Current Maturities USD 49.34M 2026-09-30 2026 Q3 10-Q 2026-11-09 0001193125-26-453585
us-gaap LossContingencyAccrualAtCarryingValue Loss Contingency Accrual USD 0 2026-09-30 2026 Q3 10-Q 2026-11-09 0001193125-26-453585
us-gaap NetCashProvidedByUsedInFinancingActivities Net Cash Provided by (Used in) Financing Activities USD 117.30M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-09 0001193125-26-453585
us-gaap NetCashProvidedByUsedInInvestingActivities Net Cash Provided by (Used in) Investing Activities USD -33.48M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-09 0001193125-26-453585
us-gaap NetCashProvidedByUsedInOperatingActivities Net Cash Provided by (Used in) Operating Activities USD -143.48M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-09 0001193125-26-453585
us-gaap NetIncomeLoss Net Income (Loss) Attributable to Parent USD -150.71M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-09 0001193125-26-453585
us-gaap NetIncomeLossAvailableToCommonStockholdersBasic Net Income (Loss) Available to Common Stockholders, Basic USD -150.71M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-09 0001193125-26-453585
us-gaap NumberOfOperatingSegments Number of Operating Segments Segment 1 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-30 0001193125-26-131782
us-gaap NumberOfReportableSegments Number of Reportable Segments Segment 1 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-09 0001193125-26-453585
us-gaap OperatingExpenses Operating Expenses USD 155.52M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-09 0001193125-26-453585
us-gaap OperatingIncomeLoss Operating Income (Loss) USD -155.52M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-09 0001193125-26-453585
us-gaap OperatingLeaseCost Operating Lease, Cost USD 2.90M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-09 0001193125-26-453585
us-gaap OperatingLeaseExpense Operating Lease, Expense USD 400,000 2020-01-01 2020-12-31 2021 FY 10-K 2022-03-01 0001564590-22-008044
us-gaap OperatingLeaseLiability Operating Lease, Liability USD 23.85M 2026-09-30 2026 Q3 10-Q 2026-11-09 0001193125-26-453585
us-gaap OperatingLeaseLiabilityCurrent Operating Lease, Liability, Current USD 3.24M 2026-09-30 2026 Q3 10-Q 2026-11-09 0001193125-26-453585
us-gaap OperatingLeaseLiabilityNoncurrent Operating Lease, Liability, Noncurrent USD 20.61M 2026-09-30 2026 Q3 10-Q 2026-11-09 0001193125-26-453585
us-gaap OperatingLeaseRightOfUseAsset Operating Lease, Right-of-Use Asset USD 13.88M 2026-09-30 2026 Q3 10-Q 2026-11-09 0001193125-26-453585
us-gaap OperatingLeaseRightOfUseAssetAmortizationExpense Operating Lease, Right-of-Use Asset, Amortization Expense USD 1.30M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-09 0001193125-26-453585
us-gaap OperatingLeasesFutureMinimumPaymentsDue Operating Leases, Future Minimum Payments Due USD 52.93M 2020-12-31 2021 FY 10-K 2022-03-01 0001564590-22-008044
us-gaap OperatingLeasesFutureMinimumPaymentsDueCurrent Operating Leases, Future Minimum Payments Due, Next Twelve Months USD 618,000 2020-12-31 2021 FY 10-K 2022-03-01 0001564590-22-008044
us-gaap OperatingLeasesFutureMinimumPaymentsDueInFourYears Operating Leases, Future Minimum Payments, Due in Four Years USD 5.04M 2020-12-31 2021 FY 10-K 2022-03-01 0001564590-22-008044
us-gaap OperatingLeasesFutureMinimumPaymentsDueInThreeYears Operating Leases, Future Minimum Payments, Due in Three Years USD 4.76M 2020-12-31 2021 FY 10-K 2022-03-01 0001564590-22-008044
us-gaap OperatingLeasesFutureMinimumPaymentsDueInTwoYears Operating Leases, Future Minimum Payments, Due in Two Years USD 4.19M 2020-12-31 2021 FY 10-K 2022-03-01 0001564590-22-008044
us-gaap OtherAccruedLiabilitiesCurrent Other Accrued Liabilities, Current USD 614,000 2026-09-30 2026 Q3 10-Q 2026-11-09 0001193125-26-453585
us-gaap OtherAssetsCurrent Other Assets, Current USD 63,000 2023-12-31 2024 Q2 10-Q 2024-08-12 0000950170-24-095401
us-gaap OtherAssetsNoncurrent Other Assets, Noncurrent USD 8.43M 2026-09-30 2026 Q3 10-Q 2026-11-09 0001193125-26-453585
us-gaap OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Adjustment, Net of Tax USD 1,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-09 0001193125-26-453585
us-gaap OtherComprehensiveIncomeLossNetOfTax Other Comprehensive Income (Loss), Net of Tax USD -72,000 2026-07-01 2026-09-30 2026 Q3 10-Q 2026-11-09 0001193125-26-453585
us-gaap OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax OCI, Debt Securities, Available-for-Sale, Unrealized Holding Gain (Loss), before Adjustment, after Tax USD -126,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-09 0001193125-26-453585
us-gaap OtherLiabilitiesCurrent Other Liabilities, Current USD 20,000 2024-06-30 2024 Q2 10-Q 2024-08-12 0000950170-24-095401
us-gaap OtherNonoperatingIncomeExpense Other Nonoperating Income (Expense) USD 303,000 2021-01-01 2021-09-30 2021 Q3 10-Q 2021-11-09 0001564590-21-055728
us-gaap OtherPrepaidExpenseCurrent Other Prepaid Expense, Current USD 831,000 2024-06-30 2024 Q2 10-Q 2024-08-12 0000950170-24-095401
us-gaap OtherReceivables Other Receivables USD 3,000 2020-12-31 2021 FY 10-K 2022-03-01 0001564590-22-008044
us-gaap PaymentsForRepurchaseOfRedeemableConvertiblePreferredStock Payments for Repurchase of Redeemable Convertible Preferred Stock USD 5.19M 2020-01-01 2020-12-31 2021 FY 10-K 2022-03-01 0001564590-22-008044
us-gaap PaymentsOfFinancingCosts Payments of Financing Costs USD 2.15M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-09 0001193125-26-453585
us-gaap PaymentsOfStockIssuanceCosts Payments of Stock Issuance Costs USD 75,000 2023-01-01 2023-09-30 2023 Q3 10-Q 2023-11-13 0000950170-23-062913
us-gaap PaymentsToAcquireAvailableForSaleSecuritiesDebt Payments to Acquire Debt Securities, Available-for-sale USD 126.34M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-09 0001193125-26-453585
us-gaap PaymentsToAcquirePropertyPlantAndEquipment Payments to Acquire Property, Plant, and Equipment USD 137,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-09 0001193125-26-453585
us-gaap PreferredStockParOrStatedValuePerShare Preferred Stock, Par or Stated Value Per Share USD/shares 0.001 2021-12-31 2021 FY 10-K 2022-03-01 0001564590-22-008044
us-gaap PreferredStockSharesAuthorized Preferred Stock, Shares Authorized shares 5.00M 2021-12-31 2021 FY 10-K 2022-03-01 0001564590-22-008044
us-gaap PreferredStockSharesIssued Preferred Stock, Shares Issued shares 0 2021-12-31 2021 FY 10-K 2022-03-01 0001564590-22-008044
us-gaap PreferredStockSharesOutstanding Preferred Stock, Shares Outstanding shares 0 2021-12-31 2021 FY 10-K 2022-03-01 0001564590-22-008044
us-gaap PrepaidExpenseAndOtherAssetsCurrent Prepaid Expense and Other Assets, Current USD 4.53M 2026-09-30 2026 Q3 10-Q 2026-11-09 0001193125-26-453585
us-gaap PrepaidExpenseCurrent Prepaid Expense, Current USD 2.38M 2020-09-30 2020 Q3 10-Q 2020-11-16 0001564590-20-054172
us-gaap PrepaidInsurance Prepaid Insurance USD 774,000 2025-12-31 2025 FY 10-K 2026-03-30 0001193125-26-131782
us-gaap PrepaidRent Prepaid Rent USD 451,000 2021-03-31 2021 Q1 10-Q 2021-05-17 0001564590-21-028390
us-gaap ProceedsFromIssuanceInitialPublicOffering Proceeds from Issuance Initial Public Offering USD 267.02M 2020-01-01 2020-12-31 2021 FY 10-K 2022-03-01 0001564590-22-008044
us-gaap ProceedsFromIssuanceOfCommonStock Proceeds from Issuance of Common Stock USD 68.39M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-09 0001193125-26-453585
us-gaap ProceedsFromIssuanceOfPrivatePlacement Proceeds from Issuance of Private Placement USD 122.50M 2022-07-01 2022-07-31 2026 Q2 10-Q 2026-08-12 0001193125-26-346779
us-gaap ProceedsFromIssuanceOfRedeemableConvertiblePreferredStock Proceeds from Issuance of Redeemable Convertible Preferred Stock USD 102.00M 2020-01-01 2020-12-31 2021 FY 10-K 2022-03-01 0001564590-22-008044
us-gaap ProceedsFromIssuanceOfWarrants Proceeds from Issuance of Warrants USD 120.98M 2022-01-01 2022-12-31 2022 FY 10-K 2023-03-06 0000950170-23-006232
us-gaap ProceedsFromLongTermLinesOfCredit Proceeds from Long-term Lines of Credit USD 49.39M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-09 0001193125-26-453585
us-gaap ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities Proceeds from Maturities, Prepayments and Calls of Debt Securities, Available-for-sale USD 93.00M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-09 0001193125-26-453585
us-gaap ProceedsFromNotesPayable Proceeds from Notes Payable USD 500,000 2020-01-01 2020-12-31 2021 FY 10-K 2022-03-01 0001564590-22-008044
us-gaap ProceedsFromSaleOfAvailableForSaleSecurities Proceeds from Sale of Available-for-sale Securities USD 7.99M 2021-01-01 2021-09-30 2021 Q3 10-Q 2021-11-09 0001564590-21-055728
us-gaap ProceedsFromSaleOfAvailableForSaleSecuritiesDebt Proceeds from Sale of Debt Securities, Available-for-sale USD 5.99M 2021-01-01 2021-12-31 2022 FY 10-K 2023-03-06 0000950170-23-006232
us-gaap ProceedsFromStockOptionsExercised Proceeds from Stock Options Exercised USD 1.19M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-09 0001193125-26-453585
us-gaap ProceedsFromStockPlans Proceeds from Stock Plans USD 487,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-09 0001193125-26-453585
us-gaap PropertyPlantAndEquipmentGross Property, Plant and Equipment, Gross USD 20.11M 2026-09-30 2026 Q3 10-Q 2026-11-09 0001193125-26-453585
us-gaap PropertyPlantAndEquipmentNet Property, Plant and Equipment, Net USD 9.16M 2026-09-30 2026 Q3 10-Q 2026-11-09 0001193125-26-453585
us-gaap ReclassificationsOfTemporaryToPermanentEquity Reclassifications of Temporary to Permanent Equity USD 6.30M 2020-01-01 2020-12-31 2021 FY 10-K 2022-03-01 0001564590-22-008044
us-gaap RepaymentsOfNotesPayable Repayments of Notes Payable USD 500,000 2020-01-01 2020-12-31 2021 FY 10-K 2022-03-01 0001564590-22-008044
us-gaap ResearchAndDevelopmentExpense Research and Development Expense USD 123.74M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-09 0001193125-26-453585
us-gaap RestrictedCash Restricted Cash USD 1.03M 2026-09-30 2026 Q3 10-Q 2026-11-09 0001193125-26-453585
us-gaap RestrictedCashNoncurrent Restricted Cash, Noncurrent USD 1.03M 2026-09-30 2026 Q3 10-Q 2026-11-09 0001193125-26-453585
us-gaap RetainedEarningsAccumulatedDeficit Retained Earnings (Accumulated Deficit) USD -1.07B 2026-09-30 2026 Q3 10-Q 2026-11-09 0001193125-26-453585
us-gaap RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability Right-of-Use Asset Obtained in Exchange for Operating Lease Liability USD 21.08M 2021-01-01 2021-12-31 2022 FY 10-K 2023-03-06 0000950170-23-006232
us-gaap ShareBasedCompensation Share-based Payment Arrangement, Noncash Expense USD 14.08M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-09 0001193125-26-453585
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Forfeited in Period shares 288,673 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-09 0001193125-26-453585
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Forfeitures, Weighted Average Grant Date Fair Value USD/shares 4.65 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-09 0001193125-26-453585
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period shares 1.86M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-09 0001193125-26-453585
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period, Weighted Average Grant Date Fair Value USD/shares 5.38 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-09 0001193125-26-453585
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number shares 2.32M 2026-09-30 2026 Q3 10-Q 2026-11-09 0001193125-26-453585
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value USD/shares 4.72 2026-09-30 2026 Q3 10-Q 2026-11-09 0001193125-26-453585
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Vested in Period shares 501,341 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-09 0001193125-26-453585
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Vested in Period, Weighted Average Grant Date Fair Value USD/shares 3.69 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-09 0001193125-26-453585
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Volatility Rate pure 0.933 2025-07-01 2025-09-30 2026 Q3 10-Q 2026-11-09 0001193125-26-453585
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Volatility Rate, Maximum pure 0.923 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-09 0001193125-26-453585
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Volatility Rate, Minimum pure 0.896 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-09 0001193125-26-453585
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Risk Free Interest Rate pure 0.04 2025-07-01 2025-09-30 2026 Q3 10-Q 2026-11-09 0001193125-26-453585
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Risk Free Interest Rate, Maximum pure 0.049 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-09 0001193125-26-453585
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Risk Free Interest Rate, Minimum pure 0.037 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-09 0001193125-26-453585
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized Share-based Compensation Arrangement by Share-based Payment Award, Number of Additional Shares Authorized shares 1.53M 2021-01-01 2021-09-30 2021 Q3 10-Q 2021-11-09 0001564590-21-055728
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant Share-based Compensation Arrangement by Share-based Payment Award, Number of Shares Available for Grant shares 1.54M 2026-09-30 2026 Q3 10-Q 2026-11-09 0001193125-26-453585
us-gaap SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1 Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Intrinsic Value USD 4.87M 2026-09-30 2026 Q3 10-Q 2026-11-09 0001193125-26-453585
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Number shares 12.87M 2026-09-30 2026 Q3 10-Q 2026-11-09 0001193125-26-453585
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Weighted Average Exercise Price USD/shares 7.95 2026-09-30 2026 Q3 10-Q 2026-11-09 0001193125-26-453585
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period, Intrinsic Value USD 700,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-09 0001193125-26-453585
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures in Period shares 1.42M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-09 0001193125-26-453585
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross shares 6.61M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-09 0001193125-26-453585
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Intrinsic Value USD 10.26M 2026-09-30 2026 Q3 10-Q 2026-11-09 0001193125-26-453585
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Number shares 23.49M 2026-09-30 2026 Q3 10-Q 2026-11-09 0001193125-26-453585
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Exercise Price USD/shares 6.36 2026-09-30 2026 Q3 10-Q 2026-11-09 0001193125-26-453585
us-gaap ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice Share-based Compensation Arrangements by Share-based Payment Award, Options, Exercises in Period, Weighted Average Exercise Price USD/shares 3.44 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-09 0001193125-26-453585
us-gaap ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice Share-based Compensation Arrangements by Share-based Payment Award, Options, Forfeitures in Period, Weighted Average Exercise Price USD/shares 5.84 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-09 0001193125-26-453585
us-gaap ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice Share-based Compensation Arrangements by Share-based Payment Award, Options, Grants in Period, Weighted Average Exercise Price USD/shares 5.17 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-09 0001193125-26-453585
us-gaap StockholdersEquity Stockholders' Equity Attributable to Parent USD 142.79M 2026-09-30 2026 Q3 10-Q 2026-11-09 0001193125-26-453585
us-gaap StockIssuedDuringPeriodSharesStockOptionsExercised Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period shares 346,960 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-09 0001193125-26-453585
us-gaap StockIssuedDuringPeriodValueConversionOfConvertibleSecurities Stock Issued During Period, Value, Conversion of Convertible Securities USD 241.42M 2020-01-01 2020-12-31 2021 FY 10-K 2022-03-01 0001564590-22-008044
us-gaap StockIssuedDuringPeriodValueEmployeeStockPurchasePlan Stock Issued During Period, Value, Employee Stock Purchase Plan USD 487,000 2026-04-01 2026-06-30 2026 Q3 10-Q 2026-11-09 0001193125-26-453585
us-gaap StockIssuedDuringPeriodValueNewIssues Stock Issued During Period, Value, New Issues USD 2.52M 2026-07-01 2026-09-30 2026 Q3 10-Q 2026-11-09 0001193125-26-453585
us-gaap StockIssuedDuringPeriodValueStockOptionsExercised Stock Issued During Period, Value, Stock Options Exercised USD 398,000 2026-07-01 2026-09-30 2026 Q3 10-Q 2026-11-09 0001193125-26-453585
us-gaap SubleaseIncome Sublease Income USD 0 2024-01-01 2024-12-31 2024 FY 10-K 2025-03-03 0000950170-25-030849
us-gaap TemporaryEquityAccretionToRedemptionValue Temporary Equity, Accretion to Redemption Value USD 279,000 2020-01-01 2020-03-31 2021 Q2 10-Q 2021-08-16 0001564590-21-044624
us-gaap TemporaryEquityAccretionToRedemptionValueAdjustment Temporary Equity, Accretion to Redemption Value, Adjustment USD 705,000 2020-01-01 2020-12-31 2021 FY 10-K 2022-03-01 0001564590-22-008044
us-gaap UnrecognizedTaxBenefits Unrecognized Tax Benefits USD 9.70M 2025-12-31 2025 FY 10-K 2026-03-30 0001193125-26-131782
us-gaap UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions Unrecognized Tax Benefits, Decrease Resulting from Prior Period Tax Positions USD 673,000 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-30 0001193125-26-131782
us-gaap UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued Unrecognized Tax Benefits, Income Tax Penalties and Interest Accrued USD 0 2025-12-31 2025 FY 10-K 2026-03-30 0001193125-26-131782
us-gaap UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense Unrecognized Tax Benefits, Income Tax Penalties and Interest Expense USD 0 2021-01-01 2021-12-31 2021 FY 10-K 2022-03-01 0001564590-22-008044
us-gaap UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions Unrecognized Tax Benefits, Increase Resulting from Current Period Tax Positions USD 1.96M 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-30 0001193125-26-131782
us-gaap UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions Unrecognized Tax Benefits, Increase Resulting from Prior Period Tax Positions USD 0 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-30 0001193125-26-131782
us-gaap ValuationAllowanceDeferredTaxAssetChangeInAmount Valuation Allowance, Deferred Tax Asset, Increase (Decrease), Amount USD 43.90M 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-30 0001193125-26-131782
us-gaap VariableLeasePayment Variable Lease, Payment USD 1.20M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-09 0001193125-26-453585
us-gaap WeightedAverageNumberOfDilutedSharesOutstanding Weighted Average Number of Shares Outstanding, Diluted shares 199.99M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-09 0001193125-26-453585
us-gaap WeightedAverageNumberOfShareOutstandingBasicAndDiluted Weighted Average Number of Shares Outstanding, Basic and Diluted shares 38.56M 2022-01-01 2022-03-31 2022 Q1 10-Q 2022-05-09 0000950170-22-008494
us-gaap WeightedAverageNumberOfSharesOutstandingBasic Weighted Average Number of Shares Outstanding, Basic shares 199.99M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-09 0001193125-26-453585

Financialist News Desk

Our desk turns official SEC filings into news. Each story is checked against the original filing. About us → · Editorial standards →